Robert M. Myers
Gründer bei Orbus Therapeutics, Inc.
Aktive Positionen von Robert M. Myers
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - | |
| Gründer | - | - | |
| Präsident | - | - |
Karriereverlauf von Robert M. Myers
Ehemalige bekannte Positionen von Robert M. Myers
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cogentus Pharmaceuticals, Inc.
 Cogentus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA | Direktor/Vorstandsmitglied | - | 18.12.2009 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01.01.2002 | 01.01.2003 |
| ALZA CORPORATION | Corporate Officer/Principal | 01.01.1992 | 01.01.2001 |
| JAZZ PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 03.04.2009 | - |
| Präsident | 03.04.2009 | - |
Ausbildung von Robert M. Myers
| Stanford University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Irland | 2 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| President | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Cogentus Pharmaceuticals, Inc.
Cogentus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA | Health Technology |
Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Health Technology |
- Börse
- Insiders
- Robert M. Myers
- Erfahrung